Royal DSM, a global purpose-led science-based company, today announces the repurchase, starting 10 March 2022, of 1,330,000 ordinary shares. 315 pages . Downloads - DSM Integrated Annual Report 2022 In line with market expectations, DSM reported EBITDA of 1,168 million compared to 1,261 million in 2013. DSM to repurchase 3,200,000 ordinary shares to cover commitments under management and personnel option plans and as part of the final dividend 2015. DSM intends to repurchase of 2,500,000 ordinary shares to cover commitments under management and personnel option plans. DSM repurchased 142,315 shares from 1 to 7 September 2017 at an average price of 65.01. Partnership with Ministry of Health Care of the Republic of Tatarstan aims to modernize the Republics public health sector through fortified nutrition. Royal DSM, a global purpose-led science-based company, has repurchased 142,403 of its own shares in the period from 18 April 2022 up to and including 22 April 2022 at an average price of 155.73. Report by . Chris Goppelsroeder to retire on 1 April 2021 with DSM's Co-CEO Dimitri de Vreeze stepping into the role. Person who is not a QIB, or in respect of whom no U.S. Investor Letter is received before 17:40 hours CET on the Acceptance Closing Date, will be a Restricted Shareholder and will be treated as set out under section 14.35 (Notice to DSM Shareholders in certain jurisdictions) of the Offering Circular. All seven members of the Executive Committee to purchase shares in Royal DSM by converting 50% of their gross STI's into ordinary shares. Annual General Meeting of Shareholders 2022 | DSM - @corporate Downloads - DSM Integrated Annual Report 2021 The health and well-being of people is core to DSMs long-standing purpose so, within the context of considerable workplace change and societal challenges, DSM implemented various initiatives throughout the year to support employees and their families, from nutrition and immunity care to mental health. DSM to acquire leading player in the development, production and sale of specialty materials in India. With the integration plan in place, we now enter the final phase of the merger process and remind our shareholders to actively tender their shares in exchange for DSM-Firmenich shares.. DSM repurchased 27,328 shares from 24 to 28 August 2020 at an average price of 134.92. Bain Capital intends to acquire DSM Sinochem Pharmaceuticals, a DSM and Sinochem Group 50/50 joint venture, with the transaction expected to be completed in the fourth quarter of 2018 subject to customary regulatory approvals and consultations. After inclusion in the EU registry, expected in the coming weeks, it is the first time a feed additive authorised in the EU for environmental benefits can be marketed. The Exchange Offer is being made in and from the Netherlands with due observance of such statements, conditions and restrictions as are included in the Offering Circular. +31 45 578 2420, Vice-President Investor Relations Royal DSM, a global purpose-led science-based company, today held its Annual General Meeting of Shareholders. DSM in exclusive discussions with Cargill which may, or may not result in DSM's acquisition of Cargills cultures and enzymes business. 2)Revised in 2022. Shareholders to vote on Erica Mann's appointment, and Pauline van der Meer Mohr's re-appointment, as members of DSM's Supervisory Board. DSM repurchased 254,756 shares from 7 to 13 March 2014 at an average price of 47.40. Download this and previous annual reports by simply selecting the year. DSM to sell its Resins & Functional Materials and associated businesses to Covestro AG for an Equity Value of 1.6 billion. DSM repurchased 224,093 shares from 18 to 21 May 2015 at an average price of 53.18. These efforts have again been acknowledged by CDP, a leading evaluator of corporate environmental disclosure, which awarded the companys climate change strategy and water stewardship A ratings, making DSM one of only a handful of companies in its sector worldwide to achieve such recognition. DSM Media Relations DSM acquires world's leading supplier of Human Milk Oligosaccharides (HMO) for early life nutrition applications. DSM qualified as supplier of enzymes for DONG Energy - Inbicons wheat straw to cellulosic ethanol process. Geraldine Matchett and Dimitri de Vreeze, Co-CEOs, commented: DSM delivered a solid performance in 2022against a background of continued global supply chain challenges and significantlyhigher energy and raw materials costs, consolidating the strong growth of 2021. Shareholders approved all resolutions on the agenda. DSM delivers a very good nine months of the year. +31 45 578 2420 DSM delivered a good financial performance for the year and achieved the key milestones in the first year of its Strategy 2021. This, and accelerated progress in reducing value chain (scope 3) emissions along with partners, provides the foundation for DSMs net-zero by 2050 commitment. DSM repurchased 112,588 shares from 6 to 9 January 2014 at an average price of 57.88. DSM repurchased 358,500 shares from 4 to 8 November 2019 at an average price of 114.17. DSM repurchased 150,213 shares from 24 to 28 June 2019 at an average price of 108.69. DSM brings forward its regular strategic review process for the period beyond 2018 and expects to share the conclusions before the summer of 2018. DSM reports a very good H1 with strong performance across all businesses. DSM reports first quarter EBITDA from continuing operations of 272 million compared to 301 million in Q1 2013. DSM aims to continue to deliver against its strategic targets in 2018. Subject to the General Meeting of DSM-Firmenich resolving to pay this dividend, eligible DSM shareholders who tender their DSM ordinary shares for DSM-Firmenich ordinary shares will receive a total dividend of about 2.53 over 2022 (vs 2.50 over 2021). DSM reports another strong quarter in Q3 2016. DSM repurchased 176,500 shares from 18 to 24 May 2018 at an average price of 88.02. Below are the financial and regulatory press releases published during the last decade. USD 2.65 billion transaction to create global CDMO leader successfully completed. In addition, the Offering Circular has not been filed with nor recognised by the authorities of any jurisdiction other than the Netherlands. Q3 Results 2021. Incorporating essential products such as vitamins, carotenoids, eubiotics and mycotoxin risk management, as well as a wide range of impactful innovations such as methane inhibitor Bovaer and fish-oil algae-alternative Veramaris. 1 These data are subject to the On November 22, 2022, DSM-Firmenich published the Offering Circular in relation to (i) the Exchange Offer pursuant to which eligible DSM shareholders are able to exchange their DSM ordinary shares for DSM-Firmenich ordinary shares, and (ii) the admission to listing and trading of DSM-Firmenich ordinary shares on Euronext Amsterdam. Q1 Results 2021. If, at the end of the acceptance period, all Transaction Conditions have been satisfied and DSM-Firmenich has accepted the tendered DSM ordinary shares unconditionally, DSMs eligible shareholders will receive DSM-Firmenich ordinary shares on the basis of a 1:1 exchange ratio. Production of a few intermediates, mainly for Animal Nutrition & Health interrupted. DSM held a virtual Annual General Meeting of Shareholders on 6 May 2021 when shareholders approved all resolutions on the agenda. DSM declares dividend for the financial year 2014 of 1.65 per ordinary share. DSM accelerates its 30% greenhouse gas (GHG) emissions reduction target to 50% by 2030. We routinely publish our financial performance, with more detail at half and full year where we also provide updates on key milestones on our strategic journey. Royal DSM: net sales 2022 | Statista 2017 Proxy . Global Proteases Market Report 2017-2022, 2022-2027F, 2032F - GlobeNewswire DSM routinely evaluates what it can do to go further and faster toward building a resilient business with a minimal environmental footprint. DSM adds Erber Groups mycotoxin risk and gut health performance management and food and feed safety diagnostic solutions to portfolio. An introduction to DSM's Investor Relations team and how investors and analysts can contact them. March 31, 2022 British Columbia Utilities Commission Suite 410, 900 Howe Street Vancouver, BC V6Z 2N3 Attention: Mr. Patrick Wruck, Commission Secretary Dear Mr. Wruck: Re: FortisBC Energy Inc. (FEI) Natural Gas Demand-Side Management (DSM) -2021 Annual Report Attached please find the Natural Gas DSM Program 2021 Annual Report for FEI. 2019 Proxy. DSM awarded FD-Henri Sijthoff prize for the best annual report by a company listed on the AEX stock exchange in the Netherlands for its 2014 Integrated Annual Report. DSM issues 500 million 2.375% bond due 2024. Royal DSM Integrated Annual Report 2022 2 Forward-looking statements This document may contain forward-looking statements with respect to DSM's future performance and position. DSMs purpose is to create brighter lives for all which we achieve through developing products and solutions that address some of the worlds biggest challenges while simultaneously creating economic, environmental, and societal value for all its stakeholders customers, employees, shareholders, and society-at-large. 27% improvement realized despite ongoing challenging macro-economic environment. DSM will create a 75/25 joint venture with Nenter & Co., Inc., which will include all Nenters production and related assets for Vitamin E. Companies to produce highly sought-after molecules such as steviol glycosides Reb M and Reb D through fermentation. DSM expands its offering in gut health ingredients with probiotics, an attractive market segment in nutritional ingredients, growing an estimated 7% per year. DSM repurchased 153,992 shares from 8 to 14 April 2016 at an average price of 50.01. Providing the results are positive, the use of Bovaer will be further upscaled from 2023. DSM repurchased 123,006 shares from 15 to 18 April 2019 at an average price of 102.40. Tender offer to purchase all outstanding shares of common stock of Kensey Nash Corporation at a price of $38.50 per share successful. DSM repurchased 164,545 shares from 29 November to 5 December 2013 at an average price of 57.17. DSM repurchased 276,022 shares from 12 to 16 August 2019 at an average price of 108.76. Royal DSM, a global purpose-led science-based company, has repurchased 40,085 of its own shares in the period from 2 May 2022 up to and including 6 May 2022 at an average price of 156.08. DSM repurchased 128,219 shares from 22 to 28 May 2015 at an average price of 53.8102. Completing acquisition of Fortitech is another milestone in implementation of DSMs Nutrition strategy. DSM repurchased 183,500 shares from 7 to 11 October 2019 at an average price of 107.03. DSM repurchased 128,851 shares from 8 to 14 September 2017 at an average price of 66.04. DSM repurchased 195,502 shares from 27 to 31 January 2020 at an average price of 110.38. DSM repurchased 874,725 shares from 17 January 2014 up to and including 21 January 2014 at an average price of 51.85 and concludes first part of program to repurchase 4-5 million shares in total. DSM repurchased 235,605 shares from 24 to 30 March 2017 at an average price of 62.81. Market demand remained resilient in what is a challenging macro-economic environment with the rising cost inflation. DSM repurchased 80,423 shares from 3 to 7 February 2020 at an average price of 113.07. Patricia Malarkey, most recently Head of Research & Development and member of the Executive Committee at Syngenta, will join DSM as Chief Innovation Officer and member of the Executive Committee. 2022. The resulting Adjusted EBITDA margin of 15.2% had a 120bps dilutive mathematical effect from the price increases in the quarter. DSM repurchased 267,680 shares from 22 to 25 February 2016 at an average price of 43.94. 2020 Annual Report. You can also find an overview of all thefinancial and regulatory press releases disclosingprice-sensitive inside information issued during the same period. 10.0 MB. DSM named among the worldwide leaders in the Materials industry group in the Dow Jones Sustainability World Index 2014. DSM repurchased 277,686 shares from 29 May to 4 June 2015 at an average price of 53.95. DSM repurchased 134,338 shares from 31 March to 6 April 2017 at an average price of 64.04. Acquisition strengthens dairy portfolio and application know-how and expertise, particularly in the areas of cheese taste, texture and bio-preservation. DSM repurchased 198,288 shares from 22 to 28 November 2013 at an average price of 58.39. DSM repurchased 153,694 shares from 29 April to 5 May 2016 at an average price of 52.34. DSM repurchased 215,656 shares from 13 to 17 August 2018 at an average price of 89.80. 15 pages . The form of a U.S. Investor Letter will be distributed to custodians, nominees and other financial intermediaries to distribute to those they hold for in due course and is also available to QIBs from the Company. The English language version of the press release is leading. DSM repurchased 196,255 shares from 28 October to 1 November 2019 at an average price of 107.26. DSM repurchased 347,955 shares from 9 to 13 December 2019 at an average price of 114.42. DSM repurchased 136,650 shares from 19 to 22 March 2018 at an average price of 80.59. 08A-366EG and subsequent demand-side management proceeding, Public Service Company of Colorado agreed to provide 60-Day Notice to the DSM Roundtable of any proposal to add a new DSM program, reduce rebate levels, adopt new or discontinue existing meas. Euroresins, a distributor of products to the composite resins industry, sold to Cathay Investments. DSM Releases 2021 Integrated Annual Report - Perfumer & Flavorist DSM successfully issued a 500 million 1.375% bond due 2022. DSM declares a dividend for the financial year 2018 of 2.30 per ordinary share. DSM repurchased 233,975 shares from 25 to 31 May 2018 at an average price of 86.30. DSM repurchased 139,447 shares from 12 to 18 May 2017 at an average price of 66.66. Unless otherwise determined by the Company, the Exchange Offer is not being, and will not be, made, directly or indirectly, in or into, or by the use of the mails of, or by any means or instrumentality (including, without limitation, telephonically or electronically) of, interstate or foreign commerce of, or of any facilities of a national securities exchange of, the United States except to DSM Shareholders who (i) are "qualified institutional buyers" as such term is defined in Rule 144A under the U.S. Securities Act of 1933, as amended (the U.S. Securities Act, and each such person, a QIB) and (ii), to the Company's satisfaction (in its sole discretion), have duly completed and returned to the Company a letter confirming that it is a QIB and agreeing to certain transfer restrictions applicable to the DSM-Firmenich Ordinary Shares (a U.S. Investor Letter) available from the Company (each an Eligible U.S. Holder). DSM repurchased 88,350 shares from 6 to 12 April 2018 at an average price of 81.74. What still went wrong in 2022 . DSM repurchased 324,894 shares from 15 to 20 June 2018 at an average price of 88.18, concluding program to repurchase 1,600,000 shares for a total of 136.7 million. DSM repurchased 126,540 shares from 21 to 27 April 2017 at an average price of 65.81. DSM successfully issues 300 million 1.75% bond due 2019. DSM has no obligation to update the statements contained in this press release, unless required by law. Pricing actions to counter higher costs,supportedtop-line growth, however with a price-cost gap impacting near-term margins, especially in Animal, Nutrition & Health. Adjustments to organizational and operating model aim to create more agile, focused and cost efficient organization, with a stronger business and market focus and globally leveraged support functions. DSM became a Health, Nutrition & Bioscience (HNB) company, organized, as of January 1, 2022, in three business groups: Animal Nutrition & Health; Health, Nutrition & Care; and Food & Beverage. DSM has been named the worldwide leader in the Materials industry group in the Dow Jones Sustainability World Index 2016. It also contributed to reducing the environmental footprint, contributing to our sustainability goals with a positive impact on individuals, families and communities. Sergio Sevilla, Our partnership with DSM made possible the launch of our new algal-based omega-3 supplement, Algae rTG Omega-3.